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ABSTRACT 
 
Introduction: In India, Ministry of health and family welfare emphasis on 
postpartum Cu-T380A insertion which has the advantage of high motivation, 
safety and convenience for both patients and the service provider. Here we 
conducted a pilot clinical study comparing intra-caesarean Cu-T380A insertion 
and interval insertion in caesarean deliveries. Materials and Methods: A 
systematic study with 150 patients in each group recruited clients alternately. 
Group A intra-caesarean insertion and Group B interval insertion in caesarean 
deliveries. The cases were followed up at 6weeks and 6months post-insertion with 
a set of parameters. Here we look for Missed strings, Expulsion and Infection rate 
as the primary outcome measures. Complications as the secondary outcome 
measures. Results: Infection rate is found to be higher in Group A(2.3%) than 
Group B(1.6%) p=1.000 at 6th week. At 6th month, infection is higher in Group B 
(1.8%) than Group A(0.9%) p=0.617. Missed strings are found to be higher in 
intra-caesarean than interval method both at 6th week and 6th month follow up 
p=0.00 and p=0.00 respectively, hence significant. Expulsion rate is found to be 
higher in Group A(2.5%) than Group B(1.7%) p=1.000 at 6th week. At 6th month 
there is no IUCD expulsion in Group A (0%) than in Group B where there is 
(1.9%) expulsion p=0.497.There is no complications such as uterine perforation 
and  contraceptive  failures in both groups during the study period. On statistical  
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analysis, it is found that there is no significant difference in infection and 
expulsion rate between the groups. For missed strings there is a significant 
difference between the groups with more missed strings in intra-caesarean 
method.Conclusion: To conclude that, intra-caesarean method is equally effective 
as interval method without any added complications for contraception in 
caesarean deliveries, with added advantage of high motivation, good compliance, 
and safety and easy for provider to deliver the services. 
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INTRODUCTION [2] 
The approach to contraception has often been manipulated and 
constrained by forces from outside the medical community includes social, 
religious, and political groups have been particularly intrusive and coercive in the 
area of family planning. Government of India, as part of Family Planning, 
introduced Cu-T380A in 2002 by replacing the previous Cu-T 200.The 
acceptance of (IUCD) continues to remain less than 2%, out of the total CPR of 
48.5%.[2] 
National Population Policy 2000 aims to attain a stable population, 
gender and demographic balance by 2045 by providing affordable and quality 
health care. Providing quality contraception services to women is one of the 
cornerstone for MDG goals of improved maternal and child health.[1,2] 
Unwanted and mistimed pregnancy results in adverse outcomes for both 
mother and child. A large proportion of women in the postpartum period want to 
accept a contraception method to regulate their fertility either by spacing or 
limiting future pregnancies. 
 Accordingly, the postpartum family planning services need to be 
strengthened and the providers are to be updated on recent developments in 
contraceptive services. Postpartum IUCD is an important step towards reducing 
the unmet need for contraception in the post- partum period and for promoting 
maternal and child health.[2] 
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Access to safe and effective contraceptive services in the postpartum 
period is of utmost importance for a woman to prevent unwanted / mistimed 
pregnancy. Immediate postpartum insertion of IUCD is being seen as an effective 
and safe contraception which can be accepted by the woman immediately after 
delivery.[1,2] 
Out of a variety of contraceptive methods with variable effectiveness 
our study deals with postpartum insertion of Intrauterine device (IUCD) Cu-T 
380A.Here the question arises, 
 Why postpartum IUCD insertion?  
 Why not interval insertion?  
 
Earlier it was found that Postpartum IUCD Insertion was associated 
with higher rates of infection and expulsion rate. It is more when insertion is 
between 72hrs  and up to6weeks after deliveries. But recent studies had showed 
decreased rate of infection and expulsion rate when insertion is accomplished 
Postpartum within 48hrs following deliveries. Hence in this study postpartum 
IUCD insertion stands its position.[1,2,3] 
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AIM OF THE STUDY 
 Clinical study to assess the acceptability, effectiveness and safety 
of immediate intra-caesarean IUCD insertion compared with extended 
postpartum (Interval) IUCD insertion in caesarean deliveries. 
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OBJECTIVES 
 
1. To study the age distribution, parity acceptance, education status 
complications and removal rates of intra-caesarean and interval IUCD 
insertion in caesarean deliveries. 
 
2. To assess the Missed string rate between intra-caesarean and interval IUCD 
insertion in caesarean deliveries.  
 
3. To assess the Expulsion rate between intra-caesarean and interval IUCD 
insertion in caesarean deliveries.  
 
4. To assess the Infection rate between intra-caesarean and interval IUCD 
insertion in caesarean deliveries. 
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REVIEW OF LITERATURE 
 
ANATOMICAL CHANGES OF POSTPARTUM UTERUS AND 
CERVIX 
 
After delivering the placenta the uterine fundus reach the level of 
umbilicus. The postpartum uterus weighs 1 kg. and measures length of 
about 25-30 cm from cervix to uterine fundus. During the immediate 
postpartum, the uterine contractions will be regular, and co-ordinated. The 
intensity and frequency of uterine contractions will be reduced after a day 
postpartum. The postpartum uterus forms a smooth cavity with both 
anterior and posterior wall apposing which measures 4-5 cm thick. The 
walls of the uterus are soft which may subject to perforation. Lower uterine 
segment is contracted in immediate postpartum period. This changes in 
uterus made the provider to be mistaken that they reached the uterine 
fundus resulting in expulsion in PPIUCD insertion in vaginal deliveries. By 
the fourth week, uterus is well involuted and become a pelvic organ. Cervix 
will be collapsed, and later contracts. Upto 48 hours after delivery,  
PPIUCD can be inserted with kelly’s placental forceps easily following a 
vaginal delivery. 
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HISTORY OF IUCD: [5,9.10] 
 
The history of IUCDs dates back to early 1900s. The first IUCD was 
developed by Dr. Richter of Walden burg. The device was made of silkworm gut. 
Dr. Ernst Grafenberg created the first Ring IUCD called Grafenberg's 
ring. It is made of silver. Along with Dr.H.Hall and Dr. M. Stone, he created Hall 
Stone ring made of stainless steel. 
The history of lippes loop dates back to 1950, coined after Dr Jack 
Lippes.  Lippes loop is made of thermoplastic, which can bend for insertion. He 
also added the nylon string to the loop for its easier removal.Later, the   Lippes 
Loop IUCD became most populous IUCD among the first generation IUCDs. 
In the year 1960, the term ‘T’ in copper T is coined after Dr Howard 
Tatum, which signifies the T shape of the IUCD. This T shape prevents its 
expulsion when uterus is contracted. Then, he finally discovered the Cu-T380A 
which is currently the preferred copper IUCD under government of India. Jaime 
Zipper discovered the spermicidal effect of copper. 
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TYPES OF INTRAUTERINE DEVICES [3,4,5] 
 
 
IUCDs that are chemically inert are composed of a nonabsorbable 
material, polyethylene, and with barium for radiopacity.eg: bows, rings, lippes 
loops,spirals, coils. Among the above lippes is commonly used  first generation 
IUCDs 
IUCDs that are chemically active have continuous elution of drug. At 
the present time, only chemically active IUCDs are available.eg: COPPER-7,Cu-T 
200B,Cu-T 220C,Cu-T 380A, NOVA-T, MULTILOAD Cu250/Cu374. 
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The Copper T IUCD 380 A  
 
 It is a T shaped IUCD made of  polyethylene and with barium sulfate 
for radiopacity. The vertical arm measures 3.6 cm and horizontal arm measures 
3.2 cm. The stem is wound with 314 mm2 of fine copper wire, and the arms each 
have 33-mm2 copper, thus totalling 380 mm2surface area of copper. The copper in 
Cu T 380A weighs 176 mg in vertical arm and 66.5 mg of copper in horizontal 
arm. The small copper bands on the horizontal arm of the T, ensures copper  
release at high in the fundus of the uterus.   
 
A thin white string, made of polyethylene is attached  at the bottom of 
the stem through a 3 mm ball on the stem. The string is meant for easy removal, 
and the ball is to prevent cervical perforation.  
 
CuT 380A  is the IUCD , that is supplied from Government of India 
from the year 2002. CuT 380A is available in a pre-packed with a loader. CuT 
380A is used in the postpartum IUCD insertion. 
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MECHANISM OF ACTION [3,6] 
These mechanisms have not been defined precisely and are the subject of ongoing 
controversy.  
 IUCD creates a foreign body milieu in the uterine cavity rendering the 
spermatozoa immobile or difficult in motion. 
 A foreign body within the uterus provokes uterine contractility through 
prostaglandin release and increases the tubal peristalsis so that the fertilized 
egg is propelled down the fallopian tube more rapidly before the 
endometrium is receptive and so preventing from implantation 
 Interference with successful implantation of the fertilized ovum, which at 
one time was believed to be the main mode of action, is less important than 
prevention of fertilization. 
 The presence of Cu T causes local inflammatory response  in the uterus, 
especially,lysosomal activation and other inflammatory actions that are 
spermicidal. 
 If unlikely,fertilization does occur, the  inflammatory reaction damages the 
blastocyst. 
 The endometrium becomes unfavourable environment for implantation. 
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EFFECTIVENESS [1,2,5] 
Cu T 380A IUCD is a long term, reversible method of contraception. Its 
effective life is upto 10 years from the date of insertion. IUCD has 1-year 
continuation rates higher than that of oral contraceptives. Their effectiveness is 
similar overall to that of tubal sterilization. Importantly, the unwanted pregnancy 
rate will decreases gradually after the 1st year of use. Average annual failure rate 
(Pregnancy rate) was 0.4%(0.5 % – 0.8 %). Average cumulative failure rate over 
12 years is 2.2%.   
Expulsion rate and removal rate of CuT 380 A is 5% and 14% respectively. 
 
THE TIMING OF INSERTION OF IUCD: [1] 
I: IMMEDIATE POSTPARTUM: 
 
 Postplacental: Insertion within 10 minutes after expulsion of the placenta 
following a vaginal delivery. 
 Intracaesarean: Insertion during a caesarean delivery, after removal of the 
placenta and before closure of the uterine incision. 
 Within 48 hours after delivery: Insertion within 48 hours of delivery and 
before discharge from the postpartum ward. 
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II: POSTABORTION: Insertion following an abortion, if there is no infection, 
bleeding or any other contraindications. 
III: EXTENDED POSTPARTUM / INTERVAL: Insertion any time after 6 weeks 
postpartum. 
INSERTION TECHNIQUE:  
For  Intracaesarean insertion: After removing  placenta in-toto. The uterus is 
inspected for any malformations which would limit the use of IUCD. Ensured that 
the nurse has opened IUCD on the sterile field. Uterus stabilized by grasping it at 
fundus. The IUCD is introduced through the uterine incision and placed at the 
uterine fundus. This is done manually between two fingers. No  attempt is made 
to pass the strings of the IUCD through the cervical os before closure of the 
uterus. Instead the strings can be pointed towards the cervix and leave it lower 
down in the uterine cavity. This is to prevent uterine infection by contamination 
of the uterine cavity with vaginal flora, and to prevent displacement of the IUCD 
from the fundus by drawing the strings downward toward the cervical canal. Care 
should be taken during closure of the uterine incision that the strings of the 
IUCD do not get included into the suture.[1] 
 
For Interval IUCD insertion (Withdrawal technique) First rule out any 
contraindications, then counsel the woman regarding various problems associated 
with IUCD use. Obtain written informed consent. A non-steroidal anti-
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inflammatory agent is given. Under aseptic precaution pelvic examination is done. 
Size and position of the uterus is identified. Any adnexal pathologies to be ruled 
out and should be evaluated if abnormalities are present. If any abnormal 
Mucopurulent discharge is present should be treated before IUCD insertion. 
Under aseptic precaution perineal parts painted and drapped with povidone 
iodine. Grasp the cervix with vulsellum. The cervical canal and uterine cavity are 
first straightened by applying gentle traction on the vulsellum. The uterus is 
sounded to identify the depth and direction of the uterus. No Touch Technique: 
Open the copper T 380 A partially, then the arms of the T are placed inside the 
insertion tube by folding the arms. Fix the flange according to utero-cervical 
length. Align the flange and the folded arms of the T in horizontal position. Insert 
the IUCD within 5 minutes of loading. Insert the loaded IUCD into the cervical os 
at appropriate angle and advance it into the uterine cavity till resistance felt. Hold 
the vulsellum and insertion rod stationary and withdraw the insertion tube till it 
touches the plunger rod such that IUCD would release into the uterine cavity. 
Plunger is removed then the insertion tube removed to prevent accidental 
displacement and expulsion of CuT. The marker tail is cut 2 cm from the external 
os, vulsellum removed, observed for bleeding from the vulsellum puncture sites, 
and hemostasis checked  speculum removed. The woman is advised to report any 
apparent adverse effects promptly. 
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Insertion immediately or very soon after delivery is followed by an 
unsatisfactorily high expulsion rate. Hence recommendations has been made, 
therefore, to withhold insertion for at least 8 weeks to reduce expulsion and to 
reduce risk of perforation. However studies states that, earlier insertion has not led 
to perforation or expulsion rates significantly higher than for insertion more 
remote from pregnancy. In the absence of infection, the device may be inserted 
immediately after early abortion. Our study deal with it. [1,3] 
ADVERSE EFFECTS [3,1,2,5] 
 
EARLY 
 Uterine Perforation and Abortion 
 Uterine Cramping and Bleeding 
 Menorrhagia 
 Infection 
LATE 
 Expulsion 
 Missed strings 
 Pregnancy with device in utero 
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UTERINE PERFORATION AND ABORTION 
 
The earliest adverse effects are  associated with insertion. They include 
clinically apparent or silent  i) uterine perforation, occurs while sounding the 
uterus or during insertion. ii) abortion of an unsuspected pregnancy. The 
frequency of these complications depends on operator skill and the precautions 
taken to detect pregnancy. Perforations occur at a rate of approximately 1 per 
1000 insertions (World Health Organization, 1987). Even though IUCD may 
migrate itself through the uterine wall, yet  perforations  are more common at the 
time of insertion.  
 
 
UTERINE CRAMPING AND BLEEDING [3] 
Cramping and some bleeding are common soon after insertion. These 
persist for variable periods. Cramping can be minimized by administering a 
NSAIDS approximately 1 hour prior to insertion. The occasional increase in 
cramping with menses is controlled in a similar manner. 
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MENORRHAGIA [5,3,2] 
Menstrual blood loss is commonly doubled with use of the  Cu-T 380A 
device, and this may cause iron-deficiency anemia. Most providers measure 
hemoglobin concentration annually. Menorrhagia is a troubling side effect, and 
approximately 10 to 15 percent of women using the copper device have it 
removed because of this problem (Hatcher and associates, 1998). 
Spotting per vaginum and mild bleeding per vaginum are the commoner 
complaints of IUCD insertion which resolves spontaneously in few months. In 
case of menstrual irregularities, first rule out pregnancy (intrauterine and ectopic), 
infection and expulsion. Reassure the patient, if the patient is very much worried, 
give a short course of NSAIDS such as Ibuprofen 200-400 mg TDS. Even then if 
the complaint persists rule out gynaecological problems. If there is no 
gynaecological problems and the symptom persists, remove the IUCD. 
Sometimes, IUCD can cause excess bleeding results in anemia. Menstrual 
irregularities are the commonest complaints for the removal of IUCD. 
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INFECTION [3,4,5,] 
A variety of pelvic infection, usually polymicrobial can occur due to 
contamination of the endometrial cavity at the time of insertion. Symptoms and 
signs are vague abdominal pain, fever, dyspareunia, abnormal or excessive 
vaginal discharge. 
 With suspected infection and the patient is not willing to continue the 
IUCD, remove the IUCD, and the woman must be treated with antimicrobials. If 
the patient is willing to continue IUCD, leave the IUCD in situ and treat with 
antimicrobials, if there is no improvement after 72 hours remove the IUCD and 
continue antimicrobials.[12,14] 
The major risk of infection is at the time of insertion and does not 
increase with long-term use. There is a small increased risk of pelvic infection for 
up to the first 20 days following insertion. Currently, there is no consensus 
whether antimicrobial administration at the time of insertion reduces the incidence 
of infection. Long-term use of current IUCDs is associated with pelvic infection 
rates comparable with those associated with oral contraceptives.  
Any infection after 45 to 60 days should be considered sexually 
transmitted and treated accordingly.The only pelvic infection that has been 
unequivocally related to IUD use is actinomycosis [12,14,16]. It appears that PID 
with actinomycosis has been reported only in women wearing an IUCD.  
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Rates of colonization with actinomycosis increase with duration of use 
for plastic devices but appear to be much less for copper-releasing IUCDs.  
 
When PID is suspected in a woman wearing an IUCD, diagnosis is 
made based on CDC guideline for PID, and antibiotic therapy should be 
administered. Removal may require if symptoms does not improved after 72 
hours of management. 
 
 
IUCD[3,4,7,6,1] TIMINGOF 
INFECTION 
INFECTION RATE EXPULSION 
RATE 
WILLIAMS OG Within 20 Days  During 1st Month 
BEREK&NOVAKS Within 20 Days 1.9 Relative Risk Of PID  
DANFORTH 9/e Limited To 20days 1% 5% 
SHAWS TXT  2-5% 2-5% 
WHO RM2010 
PPIUCD 
 1% 1% 
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CDC Diagnostic Criteria for Pelvic Inflammatory Disease (PID) [16] 
Minimal criteria 
x Tenderness in the lower abdomen. 
x Cervical tenderness per vaginum. 
x Adnexal tenderness per vaginum. 
Additional criteria 
x Temp>101°F, Abnormal excessive vaginal discharge. 
x Presence of WBC on wetmount saline test (> 10/HPF suggest infection) 
x Elevated Erythrocyte sedimentation rate., Elevated CRP. 
x Lab evidence of cervical infection with (gonoccocal/ chlamydiae)  
Definitive criteria 
x HPE of endometrial biopsy showing endometritis. 
x TVS/MRI showing thick, fluid-filled tubes with or without pelvic abscess 
or tubo-ovarian mass. 
x Laparoscopy evidences consistent with PID. 
LATE ADVERSE EFFECT 
Expulsion:[3,7,2] 
i) Partial 
ii) Complete  
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IUCD can be expelled either partially or completely which may be 
unnoticed or presenting with symptoms such as irregular bleeding, pain on 
intercourse, abnormal vaginal discharge, and bleeding after intercourse.  
Expulsion is most common during the 1st month. The woman must be 
instructed to palpate the strings protruding from the vagina in squatting down and 
then inserting a finger into the vagina until the cervix is reached. The woman 
should be examined again in about a month, usually after menses, for appropriate 
placement by identifying the tail protruding from the cervix. 
 During this period Barrier contraception may be advised.IUCD 
expulsions occur in about 5% of users. Risk factors for expulsion include young 
age, nulliparity, and heavy bleeding. 
 
 
Possible Signs 
 
Complete Expulsion - Expelled IUCD seen  
Partial Expulsion - IUCD seen/felt in the cervical canal 
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MANAGEMENT: [2,1] 
 
 For complete expulsion of the IUCD.  Confirm it by USG or by radiograph. 
If the patient is willing to reinsert IUCD, reinsert it or else provide 
alternative method of contraception 
 
 For partial IUCD expulsion: Remove the IUCD and replace it if there is no 
infection or provide any alternative method. 
 
 If the IUCD embedded in cervical canal remove it. 
 
 
MISSED STRINGS 
When the tail of an IUCD cannot be visualized, the device may have 
been expelled, or it may have perforated the uterus. In either event, pregnancy is 
possible. Conversely, the tail simply may be in the uterine cavity along with a 
normally positioned device. Often, gentle probing of the uterine cavity with a long 
artery forceps or with a terminal hook retrieves the string. Never assume that the 
device has been expelled unless it was seen. [3,2,1] 
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MANAGEMENT BASED ON FINDINGS: 
 
 
 Check for strings by speculum examination. 
 If strings are able to made out leave it as such if the women wants to 
continue, if the women is not willing to continue, remove the IUCD. 
 When the strings are not visible and the device is not felt by gentle probing 
of the uterine cavity, ultrasonography can be used to ascertain if the device 
is within the uterine cavity. If these findings are inconclusive, then x-ray 
abdomen and pelvis is taken with a sound inserted into the uterine cavity to 
identify the misplaced IUCD.  
 Hysteroscopy is yet another alternative.  
 Perforations of large and small bowel and bowel fistulas, with attendant 
morbidity, have been reported remote from insertion. An extrauterine 
copper-bearing device induces an intense local inflammatory reaction and 
adhesions. Chemically inert devices usually are removed easily from the 
peritoneal cavity by laparoscopy. Copper-bearing devices are more firmly 
adherent, and laparotomy may be necessary. 
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PREGNANCY WITH IUCD IN SITU [1,2,5] 
About 1/3rdof IUCD related conceptions are due to undetected partial or 
complete expulsion of the IUCD.  
Possible Signs and Symptoms includes  
I) Missed  periods  
II) Urine pregnancy test positive  
III) Missing string 
IV) Short or long strings than usual.  
 
The IUCD users were 50% less likely to have an ectopic pregnancy 
when compared with women no using contraception. Ectopic pregnancy rate seen 
with Cu-T 380 A is 0.20 which is the lowest among various IUCDs.  
 
Management 
 
 Confirm pregnancy and trimester. If the woman is in her second or third 
trimester of pregnancy, managed according to national guidelines. 
 Rule out ectopic pregnancy if she complaints of pain which may be 
unilateral associated with abnormal vaginal bleeding, light headedness, 
giddiness.  
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 If ectopic pregnancy is suspected, proceed to appropriate management. 
 
 
 After ruling out ectopic pregnancy ,: 
1. If the pregnancy is in the first trimester, counsel the woman on the 
benefits and risks of immediate removal of the IUCD. The IUCD 
removal may increase the risk of abortion in 1st trimester and keeping 
the IUCD in place can cause abortion in second trimester, infection and 
preterm baby. 
 
2. If the woman wants IUCD to be removed, proceed if the strings are 
visible. If the strings are not visible, confirm with USG and if it is in-
situ, leave it. 
 
3. If the woman declines removal, provide ANC care as per national 
guidelines and arrange close monitoring of the pregnancy. Counsel  the 
importance of returning to the clinic immediately if she experiences 
signs of spontaneous abortion or infection any other warning signs. 
Ensure that IUCD is removed at delivery. 
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CONTRAINDICATIONS FOR IUCD INSERTION [3,5] 
 
GENERAL 
Pregnancy or h/o amenorrhoea 
Uterine anomalies. 
Acute PID or a history of PID 
Postpartum endometritis or septic abortion in the past 3 months 
Known or suspected lower genital tract malignancy. 
If the patient has multiple sexual partners 
Bleeding  p/v of unknown etiology 
Acute lower genital tract infection, as well as bacterial vaginosis, until infection is 
controlled 
Conditions associated with increased susceptibility to infections with 
microorganisms. 
Genital actinomycosis 
IUCD in-situ 
 
 
SPECIFIC 
Cu-T 380A is contraindicated (because of its copper content): 
Wilson disease 
Copper allergy 
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WHY POSTPARTUM FAMILY PLANNING? [1] 
 
  
A. Maternal and Child Health 
 
Baby born after a short birth interval has increased chances of: 
 Pre-term, being small for gestational age, death during newborn period or 
childhood 
Woman who conceives soon after a previous delivery or spontaneous or induced 
abortion faces higher risks of: 
 Anaemia, abortion, premature rupture of membranes, maternal mortality 
 
 
B. Unmet need for birth spacing [1] 
 
 Unmet need for family planning in India is 65% during the first year 
postpartum but only 26% of women are using various method of family 
planning during the 1styear postpartum. 
 8% of the women desire to have another child within the next 2 years after 
giving birth and are vulnerable to the risks of early pregnancy. 
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C. Return of fertility [1] 
 
 
 Exclusive breastfeeding: 
 
 More than 55% of women exclusively breastfeed their babies in the first 
three months following delivery, this rate drops to nearly zero by one year 
and this exposes them to risk of pregnancy. 
 
 Partially breastfeeding or not breastfeeding:  
 
Women may resume menses within 4-6 weeks of delivery and first 
ovulation may occur as early as 45 days postpartum thereby increasing the 
risk of pregnancy soon after childbirth. 
 
 Lactational Amenorrhea:  
 
Some women may experience amenorrhoea during breast feeding even if 
they are not practicing exclusive breast feeding or do not satisfy the three 
criteria of Lactational Amenorrhea Method (LAM). There is a probability 
31 
 
that ovulation may occur before the return of menstruation. Therefore, 
amenorrhea after child birth is an unreliable indicator that a woman is 
protected against pregnancy. 
 
 Return to sexual activity during the first year postpartum, approximately 
40% women return to sexual activity within the first three months and by 
10-12 months postpartum 90% have resumed sexual activity which exposes 
the woman to risk of having an unintended pregnancy. The period after 
three months, when exclusive breastfeeding is falling, menses is returning 
and couples resume sexual activity, can be considered a period of high risk 
of an unintended pregnancy. Couples will not necessarily see themselves at 
risk of pregnancy at this time and will not fully recognize the need for 
family planning. 
 
 Following an abortion, a woman’s fertility returns within 10–11 days. 
Women who have experienced a spontaneous or induced abortion should 
begin use of a contraceptive method within 48 hours to prevent an 
unintended pregnancy. 
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ADVANTAGE OF POST PARTUM CONTRACEPTION 
 
 
1. Convenience 
This method is convenient for the women since the woman leave the 
hospital with a method of contraception and she need not to return 
back to the hospital for the same. It is also convenient for the 
provider to insert the IUCD on the delivery table by using the same 
instruments for delivery. 
 
2. Safe and easy 
Immediate postpartum will ensure that the patient is not pregnant and 
the IUCD can be placed safely. 
 
3. Womens need.  
Many studies shown that the woman are willing to use postpartum  
contraception. 
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4.  Healthy mother and baby 
The recommended interval between two pregnancies is 24 months. 
The spacing should be adequate to reduce the perinatal, maternal and 
infant complications. 
 
5. Cost benefit 
It is cheap and cost effective for the government of India to meet the 
unmet need for family planning. 
 
6. Reduces Lost follow up rate: 
 
Many patients motivated for interval insertion of IUCD at the time of 
delivery may not return back due to some social reasons.  Obstacles 
for insertion is lack of skills in postpartum insertion and patients 
having difficulty in returning back for IUCD insertion.   
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COUNSELLING FOR POSTPARTUM IUCD INSERTION 
1. Patient must be counseled during antenatally, along with her husband or 
partner. This is the best time for contraceptive counseling because the 
women is free in stress of labour. But counseling for contraception 
antenatally, made the couple to worry about future issues and babies health, 
but this will be overcome by proper counseling. 
2. Patient may be counseled at the time of early labour, because at this time 
patient can give informed consent with her own decision. But in early 
labour, patient will be more worried of outcome of delivery and may not 
think for contraception. 
3. Patients should not be counseled during the active stage of labour. Because 
at that stress, patient may give consent without her willingness.  
4. For elective caesarean deliveries, patient may be counseled antenatally. 
5. For emergency caesarean deliveries, patient may either counseled prior 
antenatally or can be counseled in early labour. 
6. Patient may be counseled after delivery for IUCD insertion within 48 hours 
of delivery or for IUCD insertion after 6 weeks. 
7. Patients must be counseled by doctors/ staffs with detailed explanation of 
uses and adverse effects of IUCD. 
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STANDARDS OF CARE MAINTAINED IN POSTPARTUM METHOD.[1] 
 
 
 
1. Woman must be counselled regarding advantages, limitations, effectiveness, 
side effects and problems related to IUCD. 
 
2. The provider must explain the procedure for insertion and/or removal of the 
immediate PPIUCD. 
 
3. Woman must be screened for clinical situations as per WHO Medical 
Eligibility Criteria (MEC).Screening should take place in the antenatal period, 
as well as immediately prior to insertion, immediate postpartum. 
 
4. The woman must be counselled and offered another suitable postpartum family 
planning method if her clinical situation does not allow for insertion of the 
immediate PPIUCD. 
 
5. The provider must insert the IUCD by following all recommended clinical and 
infection prevention measures for successful insertion.  
 
6. Woman must be followed. 
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MEDICAL ELIGIBILITY CRITERIA (WHO) [1] 
The WHO Medical Eligibility Criteria form the scientific foundation for patient 
assessment regarding family planning methods. It gives detailed guidance 
regarding whether a woman with a certain condition can safely use a given 
method of family planning.  
 
Medical eligibility criteria for the immediate PPIUCD services can be grouped as 
follows: 
Category 1:(Safely use) 
 
 Immediate postplacental, immediate postpartum<48 hours or during 
cesarean section 
 
  six weeks postpartum 
 
Category 2: no conditions (Generally use) 
 
Category 3:(Generally do not use) 
 
 Between 48 hours and six weeks postpartum. 
 Chorioamnionitis. 
 Prolonged rupture of membranes (ROM)> 18 hours. 
Category 4: (Do not use) 
 
 Puerperal sepsis 
 Unresolved postpartum haemorrhage 
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MATERIALS AND METHODS 
  
This is a pilot clinical trial conducted in the Department of Obstetrics 
and Gynecology at Chengalpattu Medical college Hospital, Chengalpattu from 
October 2012 to October 2013, which was approved by Ethical Committee. 
 
 
 
Study design 
 
STUDY TYPE Interventional 
ALLOCATION Systematic (alternate basis) 
INTERVENTION MODEL            Parallel assignment 
MASKING                              No blinding 
PRIMARY PURPOSE  Contraception 
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STUDY SAMPLE: 
The study includes 300 patients out of 500 patients who were motivated in 
the labour ward, assigned 150 patients in each group systematically on alternate 
basis who gave consent.  Remaining 200 not given consent. 
 
 
STUDY GROUPS 
 
GROUP A: IUCD Cu-T 380A is inserted intrauterinely during the caesarean 
section before closing the uterine incision. 
 
GROUP B: IUCD Cu-T 380 A is inserted more than 6 weeks after delivery by 
caesarean section  in Out-patient clinic. 
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INCLUSION CRITERIA 
 
 Includes Emergency caesarean deliveries ( Primipara, Multipara not 
willing for sterilization) 
 Age more than 18yrs but less than 49 yrs. 
 > 6 wks after delivery and less than 1 year of caesarean section. 
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EXCLUSION CRITERIA 
 
 Vaginal deliveries, Abortion. 
 Between 48 hours after delivery and upto 6 weeks by caesarean section. 
 Multipara willing for sterilization. 
 Prolonged rupture of membranes > 18 hours. 
 Features suggestive of Chorioamniotis. 
 Features suggestive of Puerperal sepsis. 
 Intrapartum / Postpartum hemorrhage. 
 Contraindications of IUCD insertion such as  recurrent pelvic infections, 
lower genital tract infection. 
  Presence of  one or more fibroids. 
 Severe anemia. 
 Complicated cases such as eclampsia, heart failure 
 Uterine anomalies. 
 Purulent discharge per vaginum. 
 Extensive genital injuries. 
 Disagreement to participate in the study were excluded from this study. 
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METHODS 
 
Patients are categorized into Group A (INTRACAESAREAN IUCD 
INSERTION) and Group B (INTERVAL INSERTION IN CAESAREAN 
DELIVERIES) by their willingness after giving a proper pre-op/ pre-insertion 
counseling regarding the time of IUCD insertion. The counseling will be given by 
either post graduate or senior staff nurse on duty. By using sterile techniques, In 
Group A the Cu-T- 380-A is inserted intrauterinely in caeseraen section. In Group 
B the CuT-380-A is inserted after 6 weeks of delivery by caesarean section  by 
withdrawal technique.  
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TECHNIQUE 
 
For  Intracaesarean insertion:  
After removing  placenta in-toto. The uterus is inspected for any 
malformations which would limit the use of IUCD. Ensured that the nurse has 
opened IUCD on the sterile field. Uterus stabilized by grasping it at fundus. The 
IUCD is introduced through the uterine incision and placed at the uterine fundus. 
This is done manually between two fingers. No  attempt is made to pass the 
strings of the IUCD through the cervical os before closure of the uterus. Instead 
the strings can be pointed towards the cervix and leave it lower down in the 
uterine cavity. This is to prevent uterine infection by contamination of the uterine 
cavity with vaginal flora, and to prevent displacement of the IUCD from the 
fundus by drawing the strings downward toward the cervical canal. Care should 
be taken during closure of the uterine incision that the strings of the IUCD 
do not get included into the suture.[1] 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                                  
 
                 
 
                 
 
                 
STEPS OF INTRACAESAREAN IUCD INSERTION
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EQUIPMENTS REQUIRED FOR INTERVAL IUCD INSERTION[2,1] 
 
 
Cotton balls moistened with povidone-iodine (Betadine) 
Sterile gloves 
Sterile IUCD pack with IUCD 
Sim’s  speculum 
Vulsellum 
Sponge holding forceps 
Uterine sound 
Straight artery forceps 
Long scissors 
 
INTERVAL IUCD insertion (Withdrawal technique) 
1. First rule out any contraindications, then counsel the woman regarding 
various problems associated with IUCD use. 
2. Obtain written informed consent. 
3. A non-steroidal anti-inflammatory agent is given. 
4. Under aseptic precaution pelvic examination is done. Size and position of 
the uterus is identified. Any adnexal pathologies to be ruled out and should  
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be evaluated if abnormalities are present. If any abnormal Mucopurulent 
discharge is present should be treated before IUCD insertion. 
5. Under aseptic precaution perineal parts prepared and drapped with 
povidone iodine. Grasp the cervix with vulsellum. The cervical canal and 
uterine cavity are first straightened by applying gentle traction on the 
vulsellum. 
6. The uterus is sounded to identify the depth and direction of the uterus. 
7.  No Touch Technique: Open the copper T 380 A partially, then the arms of 
the T are placed inside the insertion tube by folding the arms. Fix the flange 
according to utero-cervical length. Align the flange and the folded arms of 
the T in horizontal position. Insert the IUCD within 5 minutes of loading.  
8. Insert the loaded IUCD into the cervical os at appropriate angle and 
advance it into the uterine cavity till resistance felt. 
9. Hold the vulsellum and insertion rod stationary and withdraw the insertion 
tube till it touches the plunger rod such that IUCD would release into the 
uterine cavity. Plunger is removed then the insertion tube removed to 
prevent accidental displacement and expulsion of CuT.. 
10. The marker tail is cut 2 cm from the external os, vulsellum removed, 
observed for bleeding from the vulsellum puncture sites, and hemostasis 
checked  speculum removed. The woman is advised to report any apparent 
adverse effects promptly. 
                  
 
                               
 
 
                           
 
 
            
 
 
           
 
Withdrawal technique -  Module 
Loaded  IUCD ready for insertion. Flange 
adjusted based on sound length
Insertion  Insertion tube withdrawn 
Thread cut at introitus level IUCD released into uterine cavity 
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POST INSERTION COUNSELLING [1,2] 
 
 
Before discharge and after insertion in interval method, all patients are 
instructed about probable side effects and complications. Patients are shown CU-
T 380 A how it looks like, its safety and told about its protection period (10 yrs.). 
Patients were informed about the checking of IUCD threads and were instructed 
to notice expulsion if any. They were advised to review in op clinic if they have 
warning signs like irregular bleeding, abdominal pain, dyspareunia, abnormal 
vaginal discharge, missing threads, and feeling of IUCD in the vagina. 
 
 
 
 
INSERTION AND FOLLOW UP MODEL 
 
 Delivery  by 
caesarean 
6-wks 
postpartum in 
caesarean 
deliveries 
6wks after 
insertion 
6 months after 
insertion 
GROUP A INSERTION  H/O, P/S, P/V, USG H/O, P/S, P/V, USG 
GROUP B  INSERTION H/O, P/S, P/V, USG H/O, P/S, P/V, USG 
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FOLLOW UP AND MONITORING 
 
Both Group A and Group B patients are asked to come for follow up 
visits after 6weks and 6 months after IUCD insertion. At each follow-up visits 
patient was questionnaire regarding lower abdominal cramps, menstrual 
irregularities, excessive vaginal discharge and expulsion & removal of IUCD. A 
speculum examination was done to visualize the threads, look for excessive or 
offensive white discharge and for excessive bleeding. A pelvic examination was 
done to rule out evidence of PID. If the threads are long they were cut, if threads 
are not seen gentle probing of cervix done to find curled strings. If we still could 
not see strings, USG was done to confirm the presence of IUCD in situ. X-ray 
abdomen and pelvis AP and lateral view are taken to rule out perforation. 
To interpret, For infection, if the patient had abdominal cramps associated with 
fever, elevated ESR, Excessive/offensive vaginal discharge would undergone wet 
mount vaginal discharge test as bed side. The presence of >10 polymorphs /High 
power field is a positive test suggestive of pelvic infection. For IUCD expulsion, 
patients with missing threads were done USG to confirm its absence. 
Missing threads: Includes IUCD threads those curled within uterine cavity, those 
cut-off spontaneously, those that expelled spontaneously and those perforated into 
abdominal cavity. 
 RESULTS AND STATISTICS 
 
AGE WISE DISTRIBUTION OF GROUPS 
 
AGE 
FREQUENCY Group A Group B Total 
P value 
18-20 11 (7%) 15 (10%) 26   
 
0.639 21-25 125 (83%) 119 (79%) 244 
26-30 14 (9%) 16 (11%) 30 
Total 150 150 300 
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MEAN AGE FOR GROUP ANALYSIS 
 
 
 
 
MEAN AGE Mean  Sd P value 
Group A 23.25 1.83  0.854 
Group B 23.21 1.92 
 
 
Unpaired t test results 
 
  P value = 0.8536 
  By criteria this difference is considered to be not statistically significant.  
 
Majority of the acceptors among the groups are in the range of 21- 25 years 
with 83% in Group A and 79% in Group B. Least acceptors are in the range of 
18-20 years with 7% in Group A and 10% in Group B. Mean age for insertion 
in Group A is 23.25 and in Group B is 23.21. 
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PARITY WISE DISTRIBUTION OF GROUPS 
 
 
PARITY Group A Group B Total 
Primi 131 (87%) 132 (88%) 263 
Second 19 (13%) 18 (12%) 37 
Total 150 150 300 
 
 
Most of the acceptors were primipara. 87% in intra caesarean and 88% 
in interval insertion.13% in intra-caesarean and 12% in interval insertion are 
second gravida. Multipara preferred the permanent method of sterilization. 
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EDUCATIONAL STATUS OF GROUPS AND METHOD OF INSERTION 
 
 
EDUCATION Group A Group B Total 
Primary school 
0  11 (7%) 11 
Mid school 
19 (13%) 15 (10%) 34 
Higher secondary 
school 89 (59%) 83 (55%)  172 
Diploma 
33 (22%) 32 (21%)  65 
Degree 
9 (6%) 9 (6%) 18 
Total 150 150 300 
 
Majority of the study people studied upto high school  59% in Group A 
and 55% in Group B. Followed by diploma 22% in Group A and 21% in Group B, 
degree holders 6% in both the groups.   
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Comparison of presence of lower abdominal cramp between groups 
 
 
Cramps  Group A Group B 
 
 
P value  
At 6th Week 10(7.9%) 8 (6.6%) 
 
 
0.676 Not significant 
At 6th Month 8(6.9%)  4 (3.6%) 
 
 
0.261 Not significant 
 
 
During the follow up, at 6 weeks, lower abdominal cramp present in 
7.9% in Group A higher than in Group B (6.6%)  p=0.676,  hence not significant 
whereas at 6th  month 6.9% in Group A higher than in Group B(3.6%)  p=0.261, 
hence not significant. 
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Comparison of presence of Menstrual irregularities between 
groups 
 
 
 
Menstrual 
Irregularities  Group A Group B 
 
 
P value  
At 6th Week 8 (6.3%)  4 (3.3%) 
 
0.260 Not significant 
At 6th Month 4 (3.4%) 2 (1.8%) 
 
0.433 Not significant 
 
 
At 6 weeks, Menstrual irregularities present in 6.3%in Group A higher 
than in Group B (3.3%) p=0.260, hence not significant. Whereas at 6th month 
3.4% in Group A higher than in Group B (1.8%)  p=0.433, hence not significant.  
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Comparison of presence of Excessive vaginal discharge between 
groups 
 
 
 
 
Excessive 
Vaginal 
Discharge 
Group A Group B 
 
 
P value  
At 6th Week 
11(8.7%) 12(9.8%) 0.828 
Not significant 
At 6th Month 
5(4.3%) 6(5.3%) 0.765 
Not significant 
 
 
 
At 6 weeks, excessive vaginal discharge present in 8.7% in Group A 
lower than in Group B (9.8%) p=0.828, hence not significant whereas at 6th month 
4.3% in Group A lower than in Group B(5.3%)  p=0.765, hence not significant. 
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Comparison of IUCD removal by patients between groups 
 
 
IUCD Removed  Group A Group B 
 
P value  
At 6th Week 4 (3.2%) 3 (2.5%) 
 
0.734 Not significant 
At 6th Month 10 (8.6%) 4 (3.6%) 
 
0.112 Not significant 
 
 
At  6 weeks in group A 4 has removed IUCD. Among them 3 removed 
due to social reason. One removed due to menstrual irregularity. In GroupB 3 has 
removed IUCD. Among them 2 removed due to menstrual irregularities. One due 
to excessive white discharge. 
At  6 months in group A 10 has removed IUCD. Among them 6 
removed due to social reason. Two  removed due to menstrual irregularity. One 
due abdominal pain. One due to partial expulsion. In GroupB 4 has removed 
IUCD. Among them 3 removed due to menstrual irregularities. One due to social 
reasons. 
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COMPARISION OF MISSED STRINGS BETWEEN GROUPS 
 
 
Missed strings 6 weeks 6 months 
Group  A Group B Group  A Group B 
Threads not seen 74(58.8%) 9(7.4%) 62(53.4%) 9(8.0%) 
IUCD removed 4(3.2%) 3(2.5%) 10(8.6%) 4(3.6%) 
Expelled  3(2.5%) 2(1.7%) 0(0.0%) 2(1.9%) 
Missed strings 67(53.2%) 4(3.2%) 52(44.8%) 3(2.6%) 
 
P value 
0.000 0.000 
significant significant 
 
Here threads not seen includes those expelled and those removed 
IUCD. Missed string were calculated by deducing those expelled and those 
removed from threads not seen. 
 At 6 weeks, Missed String present in 53.2%in Group A higher than in 
Group B (3.2%) p=0.000, hence significant whereas at 6th  month 44.8% in Group 
A higher than in Group B(2.6% )  p=0.000, hence significant. This is due to the 
curling of strings within the uterine cavity in intracaesarean technique. 
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COMPARISON OF EXPULSION BETWEEN GROUPS 
 
 
Expulsion  6 weeks 6 months 
Group  A Group B Group  A Group B 
IUCD not seen on 
USG 
7(5.6%) 5(4.1%) 10(8.6%) 6(5.4%) 
IUCD removed 4(3.2%) 3(2.5%) 10(8.6%) 4(3.6%) 
Expelled  3(2.5%) 2(1.7%) 0(0.0%) 2(1.9%) 
 
P value 
1.000 0.497 
Not significant Not significant 
 
Here USG is done for those who had threads not seen. Expulsion 
calculated by deducing those with threads from  the total follow up excluding 
those removed. 
Expulsion rate is found to be higher in Group A (2.5%) than Group B 
(1.7%) p=1.000 at 6th week. At 6th month there is no IUCD expulsion in Group A 
(0%) than in Group B where there is (1.9%) expulsion p=0.497 
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FOLLOW UP AT 6TH WEEK 
 
 
6TH WEEK follow up GROUP A 
n=126 
GROUP B 
n=122 
P VALUE 
Lower abdominal cramp 10(7.9%) 8(6.6%) 0.676 
Presence of Menstrual 
irregularities 
8(6.3%) 4(3.3%) 0.260 
Excessive vaginal discharge 11(8.7%) 12(9.8%) 0.828 
Infection  3(2.3%) 2(1.6%) 1.000 
H/o of IUCD removal 4(3.2%) 3(2.5%) 0.734 
Threads seen on per speculum 52(41.3%) 113(92.6%) 0.000 
IUCD not found (confirmed by 
Ultrasonogram) 
7(5.6%) 5(4.1%)  
IUCD expelled 3(2.5%) 2(1.7%) 1.000 
Missed strings 67(53.17%) 4(3.2%) 0.000 
Lost follow up n=150 24(16.0%) 28(18.7%) 0.647 
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At 6th week follow up visit, among the 150 patients each in Group A 
and Group B, 7.9% in Group A and 6.6% in Group B are associated with lower 
abdominal cramps. 6.3% and 3.3% in Group A and Group B respectively are 
associated with menstrual irregularities.8.7% and 9.8% in Group A and Group B 
respectively gives complaints of excessive /abnormal vaginal discharge. 3.2% in 
Group A and 2.5% in Group B gave the h/o of IUCD removal. Among the 
examined patients, thread seen in 41.3% Group A  and 92.6% in Group B per 
speculum. In other words 58.8% and 7.4% in Group A and Group B were threads 
not seen. Those with threads not seen had undergone USG examination to 
confirm the position of IUCD. 5.6% in Group A and 4.1% in Group B had no 
IUCD in USG examination. X-ray abdomen (AP) and lateral view were taken to 
rule out perforation. 2.5% in Group A and 1.7% in Group B had complete 
expulsion of IUCD. 16%in Group A and, 18.7% in Group B didn’t turned back 
for follow up in spite of advice and letters to home. 
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FOLLOW UP AT 6TH MONTH 
 
 
6TH month follow up GROUP A 
n=116 
GROUP B 
n=112 
P VALUE 
Lower abdominal cramp 8(6.9%) 4(3.6%) 0.261 
Presence of Menstrual 
irregularities 
4(3.4%) 2(1.8%) 0.433 
Excessive vaginal discharge 5(4.3%) 6(5.3%) 0.765 
Infection  1(0.9%) 2(1.8%) 0.617 
H/o of IUCD removal 10(8.6%) 4(3.6%) 0.112 
Threads seen on per speculum 54(46.6%) 103(92.0%) 0.000 
IUCD not found (confirmed by 
Ultrasonogram) 
10(8.6%) 6(5.4%)  
IUCD expelled 0(0.0%) 2(1.9%) 0.497 
Missed strings 52(44.8%) 3(2.6%) 0.000 
Lost follow up n=150 34(22.7%) 38(25.3%) 0.685 
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At 6th month  follow up visit, among the 150 patients each  in Group A 
and Group B, 6.9% in Group A and 3.6% in Group B are associated with lower 
abdominal cramps. 3.4% and 1.8% in Group A and Group B respectively are 
associated with menstrual irregularities.4.3% and 5.3% in Group A and Group B 
respectively gives complaints of excessive /abnormal vaginal discharge. 8.6% in 
Group A and 3.6% in Group B gave the h/o of IUCD removal. Among the 
examined patients, 46.6% in Group A and 92% in Group B were threads seen per 
speculum. In other words 53.4% and 8.0% in Group A and Group B were threads 
not seen.  8.6% in Group A and 5.4% in Group B had no IUCD in USG 
examination. X-ray abdomen (AP) and lateral view were taken to rule out 
perforation. 0% in Group A and 1.9% in Group B had complete expulsion of 
IUCD. 22.7%in Group A and 25.3% in Group B didn’t turned back. 
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PURPOSE OF STATISTICAL ANALYSIS [8] 
 
To know whether the above observations  are statistically significant or 
not, we put forth hypothesis, that the relation between groups and outcomes is not 
true but occurred by chance.  
All variables were examined for outliers and non-normal distributions. The 
Categorical variables were expressed as Frequency and percentage. The Quantity 
variables were expressed as mean and standard deviation. Descriptive statistics 
were used to evaluate baseline characteristics. 
 
The group comparison for the categorical variables were analysed using 
Chi square test / Fisher Exact test  and   group comparison for quantity variables 
were analysed using Independent student t test. The p value of less than 0.05 was 
considered as statistically significant. 
 
 To analyse mean age of groups to exclude age as a confounding factor. 
 To analyse whether the relationship between the groups and outcomes 
are statistically significant or not. 
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FISHERS EXACT TEST FOR INFECTION 
 
 
AT 6 WEEKS INFECTION PRESENT ABSENT 
GROUPA   n=126 3 (2.3%) 123(97.7%) 
GROUP B  n=122 2(1.6%) 120(98.4%) 
 
 
P value = 1.0000 
The association between groups and outcomes is considered to be not 
statistically significant. 
 
 
AT 6 MONTHS INFECTION PRESENT ABSENT 
GROUPA     n=116 1(0.9%) 115(99.1%) 
GROUP B    n=112 2(1.8%) 110(98.2%) 
 
 
 
P value = 0.6168 
The association between groups and outcomes is considered to be not 
statistically significant. 
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FISHERS EXACT TEST  FOR IUCD EXPULSION 
 
AT 6 WEEKS IUCD EXPELLED NOT EXPELLED 
GROUP A   n= 122 3(2.5%) 119(97.5%) 
GROUP B   n=119 2(1.7%) 117(98.3%) 
 
 
P value = 1.0000 
The association between groups and outcomes is considered to be not 
statistically significant. 
 
 
 
AT 6 MONTHS IUCD EXPELLED NOT EXPELLED 
GROUPA    n= 106 0(0%) 106(100%) 
GROUP B   n=108 2(1.9%) 106(98.1%) 
 
  
P value = 0.4977 
The association between groups and outcomes is considered to be not 
statistically significant. 
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To summarize Results: 
 
 
 
 
At 6th week Group A  Group B P value Difference 
Missed strings 67(53.2%) >> 4(3.2%) 0.000 Significant 
IUCD expelled 3(2.5%) > 2(1.7%) 1.000 Not Significant 
Infection  3(2.3%) > 2(1.6%) 1.000 Not Significant 
Lost follow up 24(16.0%) < 28(18.7%) 0.647 Not Significant 
 
 
 
 
 
At 6th month Group A  Group B P value Difference 
Missed strings 52(44.8%) >> 3(2.6%) 0.000 Significant 
IUCD expelled 0(0.0%) < 2(1.9%) 0.497 Not Significant 
Infection  1(0.9%) > 2(1.8%) 0.617 Not Significant 
Lost follow up 34(22.7%) < 38(25.3%) 0.685 Not Significant 
 
 
There is no uterine perforation in both groups during the study period. 
There is no contraceptive failures in both groups during the study period. 
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DISCUSSION 
 
The need for contraception is highly warranted in our country since 
approximately 27% of births in India occur in less than 24 months after a previous 
birth. Another 34% of births occur between 24 and 35 months. 
 
So the term birth-to-pregnancy interval is important which is the time 
period between a live birth and the start of the next pregnancy. After a live birth, a 
woman should wait at least 24 months (but not more than five years) before 
attempting the next pregnancy. After a spontaneous or induced abortion, a woman 
should wait at least 6 months before attempting the next pregnancy.[1] 
 
During this period, women needs to be protected from pregnancy. She 
is in need of contraception. Copper containing IUCD Cu-T 380A will be the best 
option in view of easy& one-time insertion,ie..effective for 10 years and also cost-
effectiveness. Among various types of contraception our study dealswith 
Postpartum  IUCD Insertion Especially Intra-caesarean Method.The specific 
advantages of postpartum insertion includes: Convenience,High motivation, Safe 
because she is not pregnant at the time of insertion. No effect on amount and 
quality of breast milk. The woman has an effective method for contraception 
before discharge from hospital. For the service provider  it saves time as insertion 
is performed on the same delivery table. Additional evaluations and separate  
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clinical procedure is not required. Need for minimal additional instruments, 
supplies and equipment. Giving proper spacing of births results in good healing of 
uterine scar which reduces the chance of rupture uterus.[1,2] 
 
Many studies compare the expulsion rates of postplacental IUCD 
insertion among vaginal and caesarean deliveries showed lower expulsion rates 
with intracaesarean IUCD insertion. 
 
In our study we compared immediate intra-caesarean IUCD insertion 
Group A and interval insertion Group B in caesarean deliveries. Similar to 
postplacental IUCD insertion it has the advantage of high motivation, assurance 
that the woman is not pregnant, and convenience. Here we use 150 cases in each 
group. The cases were followed up at 6weeks and 6 months with set of 
parameters. Here we look for infection rate and expulsion rate as primary 
outcome measure and complications as secondary outcome measures. 
 
Our study shows majority of acceptors are in the age group of 21-25 
years as 83% in Group A and 79 % in Group B. Least acceptors are found in the 
age group of 18 – 20 years with 7% in Group A and 10% in Group B. 
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Majority of acceptors are primipara with 87% in Group A and 88% in 
Group B. Majority of acceptors belongs to  high school with 59% in Group A and 
55% in Group B. Least acceptors are in Primary School with 0% in Group A and 
7% in Group B. 
 
During the follow up, at 6 weeks, lower abdominal cramp present in 
7.9% in Group A higher than in Group B (6.6%)  p=0.676,  hence not significant 
whereas at 6th  month 6.9% in Group A higher than in Group B(3.6%)  p=0.261, 
hence not significant. 
 
At 6 weeks, Menstrual irregularities present in 6.3%in Group A higher 
than in Group B (3.3%) p=0.260, hence not significant. Whereas at 6th month 
3.4% in Group A higher than in Group B (1.8%)  p=0.433, hence not significant. 
At 6 weeks, excessive vaginal discharge present in 8.7% in Group A lower than in 
Group B (9.8%) p=0.828, hence not significant whereas at 6th month 4.3% in 
Group A lower than in Group B(5.3%)  p=0.765, hence not significant. Mexico 
study states there is no statistical differences noted among the complications of 
IUCD between the immediate and interval IUCD insertion.[21] 
 
Infection rate is found to be higher in Group A(2.3%) than Group 
B(1.6%) p=1.000 at 6th week. At 6th months infection is higher in Group B (1.8%) 
than Group A(0.9%) p=0.617. Mali study states that infection during 6 month of 
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IUCD insertion    were rare overall is less than 2% and did not differ  significantly 
by timing of insertion. 
 
 At 6 weeks, Missed String present in 53.2%in Group A higher than in 
Group B (3.2%) p=0.000, hence  significant whereas at 6th  month 44.8% in 
Group A higher than in Group B(2.6% )  p=0.000, hence significant. This is due 
to the curling of strings within the uterine cavity in intracaesarean technique. 
 
Expulsion rate is found to be higher in Group A (2.5%) than Group B 
(1.7%) p=1.000 at 6th week. At 6th month there is no IUCD expulsion in Group A 
(0%) than in Group B where there is (1.9%) expulsion p=0.497. Nathale kappa 
states that immediate insertion following caesarean delivery shows lower 
expulsion rate than immediate insertion following vaginal delivery.[20,21,22] 
 
Mexico study shows expulsion rate at 1 year follow up was 9% in 
immediate intracaesarean and 4% in interval IUCD insertion in caesarean 
deliveries. 
Mali study states expulsion rates in immediate intracaesarean over 2 
year is 11.3%. expulsion rates at 1 and 3 month are 4.1% and 10.9% respectively. 
Continuation rate of IUCD in intracaesarean technique is 78.2%. 
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At 6th week Infection and expulsion rates are found to be higher in 
intra-caesarean insertion than interval method but not significant, statistically. At 
6th month infection rate is found to be higher in intra-caesarean method and 
expulsion rate is found to be higher in interval insertion than intra-caesarean 
method (no expulsion in intra-caesarean method) but not significant, statistically. 
Missed strings are found to be higher in intra-caesarenthan interval method both 
at 6th week and at 6th month follow up. 
 
To infer, missed strings are found to be higher in intra-caesarean than 
interval method. Regarding infection and expulsion there is no significant 
difference between intra-caesarean and interval method within the period of 
6months follow up. 
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SIMILAR STUDIES 
 
1) INTRAUTERINE DEVICE INSERTION DURING THE POSTPARTUM 
PERIOD by Nathalie kapp, kathryn m. Curtis. They analysed 297 articles, all 
studies examined the outcomes of copper IUCD insertions within the postpartum 
time period compared to other time intervals. They conclude no increase in risk of 
complications who had an IUCD inserted during the postpartum period. However, 
some increase in expulsion rates occurred with delayed postpartum insertion when 
compared to immediate insertion and with immediate insertion when compared to 
interval insertion, intracaesrean cases are associated with lower expulsion rates 
than postplacental vaginal insertions, without increasing rates of postoperative 
complications.[39] 
 
 
Contraception 80 (2009) 327–336  Elsevier 
 
 
 
 
 
71 
 
 
 
 
 
2) POST-PLACENTAL INTRAUTERINE DEVICE INSERTION - a five 
year experience at a tertiary care centre in north india by ManjuShukla, 
SabuhiQureshi.They compared postplacental insertion with interval insertion. A 
total of 1317 women were included in the study. Of these, 1037 (78.7%) came for 
first follow up. The cumulative expulsion rate at the end of 6 months was 10.68 
per cent. There was no case of misplaced IUCD. They conclude that although the 
expulsion rate for immediate postpartum insertion was higher than for interval 
insertion, the benefits of providing highly effective contraception immediately 
after delivery outweigh this disadvantage, particularly in country where women  
have limited access to medical care.[38] 
 
 
Indian Journal Of Medical Research Volume 136 , 2012 
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3) IMMEDIATE POST-PARTUM INSERTION OF INTRAUTERINE 
DEVICES by David A Grimes, Laureen M Lopez, Kenneth F Schulz, Huib AAM 
Van Vliet, Nancy L. Stanwood. Theystudied nine RCT. One directly compared 
immediate post-partum insertion with delayed  intervalinsertion. Finally they 
conclude that Immediate post-partum insertion of IUCDs appeared effective, 
though comparisons with other insertion times werelimited. Expulsion rates 
appear to be higher than with interval insertion. Advantages of immediate post-
partum insertion include high motivation, assurance that the woman is not 
pregnant, and convenience. [40] 
 
 
 
The Cochrane Library 2010, Issue 5 
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SUMMARY 
To summarize, we compared intra-caesarean IUCD insertion (Group A) 
and interval insertion (Group B) in caesarean deliveries. We motivated 500 
patients out of which 300 gave willingness for the study. A systematic study 
recruited patients alternately who gave consent. The cases were followed up at 
6weeks and 6months post-insertion with a set of parameters. Here we look for 
Missed strings, Infection and Expulsion rate as the primary outcome measure. 
Complications as secondary outcome measure.  
 
During the follow up, at 6 weeks, lower abdominal cramp present in 
7.9% in Group A higher than in Group B (6.6%)  p=0.676,  hence not significant 
whereas at 6th  month 6.9% in Group A higher than in Group B(3.6%)  p=0.261, 
hence not significant. 
At 6 weeks, Menstrual irregularities present in 6.3%in Group A higher 
than in Group B (3.3%) p=0.260, hence not significant. Whereas at 6th month 
3.4% in Group A higher than in Group B (1.8%)  p=0.433, hence not significant. 
At 6 weeks, excessive vaginal discharge present in 8.7% in Group A lower than in 
Group B (9.8%) p=0.828, hence not significant whereas at 6th month 4.3% in 
Group A lower than in Group B(5.3%)  p=0.765, hence not significant. 
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Infection rate is found to be higher in Group A (2.3%) than Group B 
(1.6%) p=1.000at 6th week. At 6th months infection is higher in Group B (1.8%) 
than Group A (0.9%) p=0.617. Expulsion rate is found to be higher in Group A 
(2.5%) than Group B (1.7%) p=1.000 at 6th week. At 6th month there is no IUCD 
expulsion in Group A (0%) than in Group B where there is (1.9%) expulsion 
p=0.497. Missed strings are found to be higher in intra-caesarean than interval 
method both at 6th week and at 6th month follow up. There is no complications 
such as uterine perforation and contraceptive failures in both groups during the 
study period.  
To analyse whether they are significant or not, we putforth null 
hypothesis and analysed with Fishers Exact Test. On statistical analysis, it is 
found that there is no significant difference in occurrence of infection as well 
expulsion  in both the groups. Regarding missed strings there is significant 
difference between group with higher values for intra-caesarean method. Hence it 
is stated that both methods are equally effective for contraception in caesarean 
delivery. 
 
 
 
 
 
75 
 
 
CONCLUSION 
Based on above discussion and studies it is found that postpartum 
IUCD insertion is an excellent method of contraception. In our study we have 
shown the comparison between intra-caesarean insertion and interval insertion. 
Results shown difference in Lower abdominal cramp, Menstrual irregularities, 
Excessive vaginal discharge, Infection, Missed string and Expulsion rates 
between groups. But on statistical analysis, it is found that there is no significant 
difference in Lower abdominal cramp, Menstrual irregularities, Excessive vaginal 
discharge, infection and expulsion rate between the groups.  
For missed strings there is a significant difference between the groups 
with more Missed strings on intra-caesarean method. The other disadvantage of 
intra-caesarean method is removal of IUCD may require anaesthesia or 
hysteroscopic guidance because of high rates of missed strings. 
To conclude, intra-caesarean Cu-T 380A is equally effective as interval 
IUCD insertion without any added complications (except for high Missed string 
rates) for contraception in caesarean deliveries within the period of 6 months 
follow up, with added advantage of high motivation, good compliance, safety 
and easy for provider to deliver the services. 
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PROFORMA 
 Name: 
 Age/Sex: 
 Ip No: 
 Date of Admission: 
 Date of delivery/Lscs: 
 Date of discharge: 
 Date of Insertion of IUCD:  
 Intra Caesarean/ Extended Postpartum Insertion 
 Address For Communication / Phone No: 
 Socio-economic status: 
 
Obstetric formula:  G   P   L  A 
Obstetric history: 
Past: 
Present : 
1st  Trimester 
2nd Trimester 
3rd Trimester 
Menstrual h/o: menarche, cycles, flow      . 
 
Marital h/o:           years,   consanguinity: 
 
 
Previous Medical Illness: 
 
 H/s/o Gestational hypertension               
 H/o dilatation and curettage           
 Diabetes                                          
 Epilepsy                                             
 Migraine                                             
 H/o of STD                                    
 
 Date of LSCS: 
Indication for LSCS: 
H/o Draining / Duration : 
H/o Bleeding both antepartum / Intrapartum / postpartum : 
 
GENERAL EXAMINATION AT THE TIME OF IUCD INSERTION: 
Consciousness, orientation 
Built, nourishment                                        Height 
Pallor                                                            Weight 
Icterus                            BMI 
Pedal edema 
BP:        /     mmHg 
PR:        /   min 
Temp:    
CVS: S1S2 
RS: NVBS                                                  
PERABDOMEN: 
Inspection: 
 
Palpation: 
 
PER VAGINUM 
 
PER SPECULUM 
 
CNS:  
 
Investigations: 
 Grouping and typing. 
 Complete hemogram. 
 Urine routine. 
 Bleeding time. 
 Clotting time. 
 HIV I & II  
 VDRL 
 Ultrasonogram. 
 
 
Parameters After 6 weeks of 
insertion 
After 6 month 
of insertion 
Lower abdominal cramp   
Menstrual irregularities   
H/o of intermenstrual bleeding   
H/o dyspareunia   
H/o White discharge (Normal or 
Abnormal (time, amount, foul 
smelling) wet mount test 
  
Temperature   
Pulse rate   
Blood pressure   
Per abdomen   
Per speculum   
Per vaginum   
Ultrasound for position of IUCD   
 
 
GROUP A MASTER CHART 
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      At 6th week follow up At 6th month follow up 
1 GAYATHRI 22 6693 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
2 MOHANA 24 6820 1 5 0 0 0 0 0 1 0 0 0 0 0 1 
3 THENMOZHI 21 6934 1 3 0 0 0 0 1 4 0 0 0 0 1 4 
4 TAMILARASI 23 7874 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
5 REVATHI 24 9034 1 5 0 0 0 0 0 0 3 3 3 0 3 3 
6 BHARGAVI 26 9270 2 6 0 0 0 0 0 1 0 0 0 0 0 1 
7 AMUTHA 26 9446 2 5 0 0 0 0 0 1 0 0 0 1 0 0 
8 PRIYA 25 9584 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
9 MAHESWARI 22 9756 1 3 1 0 0 0 1 4 1 0 0 0 1 4 
10 SUDHA 24 10024 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
11 ARULMOZHI 25 10240 1 5 0 0 0 0 0 1 0 0 0 0 0 1 
12 REVATHI 25 10119 2 4 0 0 0 0 1 4 0 0 0 0 1 4 
13 REKHA 22 10009 1 5 0 0 0 0 0 1 0 0 0 0 0 1 
14 SAMUNDEESWARI 25 10838 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
15 RAMAYEE 25 10923 2 4 0 0 0 0 0 1 0 0 1 0 0 1 
16 PRIYA 22 11085 1 3 0 0 0 0 1 4 0 0 0 0 1 4 
17 ANJALI 24 11295 1 5 1 1 1 0 0 1 1 1 0 0 0 1 
18 AMIRTHAM 24 11487 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
19 PARIMALA 24 11886 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
20 DHANALAKSHMI  22 11682 1 3 0 0 0 0 1 4 0 0 0 0 1 4 
21 AMUTHA 24 12364 1 4 0 0 0 0 0 1 0 0 0 1 0 0 
22 JEYASHREE 22 13110 1 4 0 0 0 0 0 0 0 0 0 0 0 1 
23 JEYANTHI 24 12180 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
24 KALPANA 22 13164 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
25 SELVI 24 13185 1 5 0 0 0 0 1 4 0 0 0 0 1 4 
26 TAMILSELVI 22 13238 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
27 REVATHI 21 13589 1 5 0 0 0 0 0 1 0 0 0 0 0 1 
28 AMUTHA 24 13697 1 4 0 0 1 0 0 1 3 3 3 0 3 3 
29 RENUKA 25 13789 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
30 RAMYA 22 13817 1 3 0 0 0 0 0 1 0 0 0 0 0 1 
 
 
31 RAMA 22 13834 1 5 0 0 0 0 0 1 0 0 0 1 0 0 
32 RADHIKA 24 13854 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
33 VIJAYALAKSHMI 21 13648 1 3 0 0 0 0 1 4 0 0 0 0 1 4 
34 BHUVANESH 25 13798 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
35 REVATHI 23 13868 1 5 0 0 0 0 0 1 1 0 0 0 0 1 
36 SUMATHI 24 13906 1 4 0 0 0 1 0 0 3 3 3 0 3 3 
37 PUGALMATHI 24 13913 1 4 0 0 1 0 1 4 0 0 0 0 1 4 
38 MARIYAMM AL 27 13929 2 6 0 1 0 0 0 1 0 0 0 0 0 1 
39 ALOCIYA 22 13804 1 5 0 0 0 0 1 4 0 0 0 0 1 4 
40 INDIRA 23 14303 1 5 0 0 0 0 0 1 0 0 0 1 0 0 
41 STHIYA 25 14412 2 4 0 0 0 0 1 4 0 0 0 0 1 4 
42 MALLIKA 21 14497 1 3 3 3 3 0 3 3 3 3 3 0 3 3 
43 MEENAKCHI 24 14654 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
44 GAYATHRI 20 14709 1 4 0 0 0 0 0 1 0 1 0 0 0 1 
45 GOVINDAMMAL 23 14947 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
46 KANNAGI 24 15105 1 5 3 3 3 0 3 3 3 3 3 0 3 3 
47 SONIA 21 15221 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
48 AMBIKA  23 15233 1 5 0 0 0 0 1 4 3 3 3 0 3 3 
49 DEVI 24 15304 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
50 PARIMAL 25 15599 1 6 1 0 0 0 1 4 0 0 0 0 1 4 
51 DEVI 21 15613 1 3 3 3 3 0 3 3 3 3 3 0 3 3 
52 JEYANTHI 25 15615 1 5 0 0 0 0 1 4 0 0 0 0 1 4 
53 PREMALATHA 24 15976 1 4 0 1 0 0 0 1 0 0 0 1 0 0 
54 ANJALAI 26 16286 2 4 0 0 0 0 1 4 1 0 1 0 1 4 
55 SANGEETHA 24 16236 1 5 0 0 1 0 0 1 0 0 0 0 0 1 
56 SOFIYA 24 16327 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
57 SAMUNDI 25 16417 2 4 0 0 0 0 0 1 0 0 0 0 0 1 
58 DHANALAKSHMI 23 16530 1 5 1 0 0 0 1 4 0 0 0 0 1 4 
59 KAMACHI 24 16600 1 4 0 0 0 1 0 0 3 3 3 0 3 3 
60 GEETHA 24 16686 1 5 0 0 1 0 0 1 0 0 0 0 1 4 
61 PONNNI 23 18742 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
62 DHANALAKSHMI 22 18721 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
63 SANDHIYA 23 18929 1 5 0 0 0 0 1 4 0 0 0 0 1 4 
64 KALA 20 19013 1 3 0 0 0 0 0 1 0 0 0 1 0 0 
65 GOWRI 23 19230 1 4 1 1 0 0 1 4 0 0 0 0 1 4 
 
 
66 SUDHA 24 19253 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
67 VANAJA 20 19415 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
68 NEELAVATHI 23 19319 1 5 0 0 1 0 0 1 3 3 3 0 3 3 
69 GEETHA 25 19562 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
70 MANJULA 28 19657 2 6 3 3 3 0 3 3 3 3 3 0 3 3 
71 NANDHINI 22 19948 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
72 KALAIYARASI 25 19926 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
73 MAHESWARI 22 20105 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
74 KOTTESWARI 26 20136 1 6 0 0 0 0 0 1 0 0 0 0 0 1 
75 KALYANI 22 20434 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
76 SARANYA 22 20286 1 4 0 0 0 0 0 0 0 0 0 0 0 1 
77 DEVI 19 20686 1 3 3 3 3 0 3 3 3 3 3 0 3 3 
78 MEENA 21 27736 1 4 1 1 0 0 1 4 1 0 0 0 1 4 
79 KANNAIAMMAL 22 20823 1 4 0 0 1 0 0 1 0 0 0 1 0 0 
80 SANGEETHA 23 21051 1 5 0 0 0 0 1 4 0 0 0 0 1 4 
81 BHUVANA 19 20957 1 3 3 3 3 0 3 3 3 3 3 0 3 3 
82 BAVANI 21 21204 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
83 BANU 25 21314 2 5 0 0 0 0 0 1 3 3 3 0 3 3 
84 MARY KRISTINA 22 21473 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
85 MAHALAKSHMI 25 21554 1 4 0 0 0 0 1 4 0 1 0 0 1 4 
86 PATTU 21 21673 1 4 0 0 0 0 0 1 0 0 1 0 0 1 
87 NATHIYA 23 21696 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
88 SUDHA 24 21718 1 5 0 0 0 0 1 4 0 0 0 0 1 4 
89 KALA 25 21975 2 6 0 0 0 0 0 1 0 0 0 0 0 1 
90 POONGODI 22 22142 1 4 0 0 0 0 1 4 0 0 1 0 1 4 
91 GAJALAKSHMI 21 22144 1 3 0 0 0 0 0 1 1 0 0 0 0 1 
92 SHARMILA 23 22363 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
93 SATHYAPRIYA 25 22426 1 5 3 3 3 0 3 3 3 3 3 0 3 3 
94 NANDINI 20 22518 1 4 1 0 0 0 1 4 0 0 0 0 1 4 
95 UMA 25 22711 1 4 0 0 1 0 0 1 0 0 0 1 0 0 
96 SELVI 22 22856 1 3 0 0 0 1 0 0 3 3 3 0 3 3 
 
 
97 NALINI 27 22406 1 5 0 0 0 0 1 4 0 0 0 0 1 4 
98 MAHESWARI 26 22988 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
99 JEYALAKSHMI 25 23196 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
100 JEGATHA 20 22643 1 3 0 0 0 0 1 4 0 0 0 0 1 4 
101 DEVI 24 23195 1 5 3 3 3 0 3 3 3 3 3 0 3 3 
102 REVATHY 23 23345 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
103 KALPANA 24 23308 1 4 1 0 0 0 1 4 0 0 0 0 1 4 
104 HEMALATHA 24 23560 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
105 ANJALAI 23 23528 1 4 0 1 0 0 0 1 0 0 0 0 0 1 
106 KALAIVANI 24 23552 1 4 0 0 1 0 1 4 0 0 0 0 1 4 
107 PADMAVATHY 25 23793 1 5 0 0 0 0 0 1 0 0 0 0 0 1 
108 SARITHA 24 23906 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
109 SATHIYA 24 24069 1 5 0 0 0 0 1 4 0 0 0 0 1 4 
110 BHARATHI 21 22650 1 3 0 0 0 0 0 1 0 0 0 0 0 1 
111 MALA 23 24032 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
112 MARIAMMAL 23 24052 1 4 0 0 0 0 0 1 0 0 0 1 0 0 
113 LATHA 24 24296 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
114 GOVITHAMMAL 23 24289 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
115 NISHA 26 23970 2 6 0 0 0 0 1 4 0 0 0 0 1 4 
116 MALA 21 24266 1 3 0 0 0 0 0 1 0 0 0 0 0 1 
117 ADHILAKSHMI 24 24235 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
118 SARADHA 23 24353 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
119 RUBINI 22 24388 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
120 RENUKA 21 24842 1 3 0 0 1 0 0 1 0 0 0 0 0 1 
121 LOGANAYAGI 21 24529 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
122 SARALA 25 24586 1 5 0 0 0 0 1 4 0 0 0 0 1 4 
123 REVATHI 22 24581 1 4 0 0 0 0 0 1 1 1 0 0 1 4 
124  JHONCY 23 24476 1 4 1 0 0 0 0 1 0 0 0 0 0 1 
125 FATHIMA 20 24646 1 3 3 3 3 0 3 3 3 3 3 0 3 3 
126 SELVI 23 24702 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
127 SANDHIYA 23 24691 1 4 0 0 0 0 0 1 0 0 1 0 0 1 
 
 
128 MANIMEGALAI 26 24704 2 5 0 1 0 0 1 4 0 0 0 0 1 4 
129 USHA 26 24689 2 6 3 3 3 0 3 3 3 3 3 0 3 3 
130 SUGANYA 21 24834 1 4 0 0 0 0 1 4 0 0 0 0 1 4 
131 MEGALA 26 24831 2 4 0 0 0 0 0 1 0 0 0 0 0 1 
132 SONIYA 20 24715 1 3 0 0 0 0 0 1 0 0 0 1 0 0 
133 JEEVA 23 24814 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
134 JEYALAKSHMI 26 24804 2 5 0 0 0 0 1 4 0 0 0 0 1 4 
135 REVATHI 23 24882 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
136 RAJESWARI 25 24983 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
137 SUBHASHREE 21 24762 1 4 0 0 1 0 0 1 0 0 0 0 0 1 
138 JERGIN 20 25000 1 4 0 0 0 1 0 0 3 3 3 0 3 3 
139 VANITHA 25 25006 1 5 0 0 0 0 0 1 0 0 0 0 0 1 
140 DEVI 26 25084 2 6 0 0 0 0 1 4 0 0 0 0 1 4 
141 JAMUNA 22 25065 1 4 3 3 3 0 3 3 3 3 3 0 3 3 
142 MAHALAKSHMI 24 25141 1 4 0 0 0 0 0 1 0 0 0 0 1 4 
143 SULOCHANA 25 25109 1 5 0 0 0 0 0 1 0 0 0 0 0 1 
144 SUMITHA 20 25228 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
145 NIROSHA 22 25221 1 4 0 0 0 0 0 1 1 0 0 0 0 1 
146 KRISHNAVENI 22 25264 1 4 1 1 0 0 1 4 0 0 0 0 1 4 
147 KALPANA 22 23550 1 4 0 0 0 0 0 1 0 0 0 0 0 1 
148 KUSHBU 22 25116 1 4 0 0 0 0 0 1 3 3 3 0 3 3 
149 MAHESWARI 26 25204 2 4 0 0 0 0 0 1 0 0 0 0 0 1 
150 BHUVANESH  26 25358 2 4 0 0 0 0 0 1 0 0 0 0 0 1 
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      At 6th week follow up At 6th month follow up 
1 SHANMUGAPRIYA 24 6739 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
2 GEETHA 23 6949 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
3 SHENBAGAM 26 6962 2 6 0 0 0 0 1 4 0 0 0 0 1 1 
4 REVATHI 24 8054 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
5 MYTHILI 25 9396 1 4 1 0 0 1 0 0 3 3 3 3 3 3 
6 NATHIYA 19 9304 1 3 0 0 0 0 0 1 0 0 0 0 1 1 
7 KANAGAMANI 22 9420 1 4 0 0 0 0 0 1 0 0 0 0 1 1 
8 TAMILARASI 23 9725 1 5 3 3 3 3 3 3 3 3 3 3 3 3 
9 NAYAGI 20 9776 1 3 0 0 0 0 1 4 0 0 0 0 1 1 
10 SANGEETHA 24 9904 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
11 SASI 22 10140 1 4 0 1 0 0 1 4 0 0 1 0 1 1 
12 DIVYA 25 10369 2 5 0 0 0 0 1 4 0 0 0 1 0 0 
13 KAPAGAMVALLI 21 10556 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
14 JEYANTHI 22 10636 1 4 0 0 0 0 1 4 1 1 1 0 1 1 
15 ABIRAMI 24 10960 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
16 ANBARASI 26 11282 2 6 0 0 0 0 1 4 0 0 0 0 1 1 
17 RAJESWARI 19 11349 2 3 3 3 3 3 3 3 3 3 3 3 3 3 
18 VANITHA 26 11761 2 5 0 0 0 0 1 4 0 0 0 0 0 1 
19 AMMU 22 12181 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
20 SELVI 25 12637 1 2 0 0 1 0 0 1 0 0 0 0 1 1 
21 ANJALAI 21 13089 1 4 0 0 0 0 1 4 3 3 3 3 3 3 
22 ETTIYAMMAL 26 13172 2 5 0 0 0 0 1 4 0 0 0 0 1 1 
23 RIHAANA 23 13249 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
24 TULASI 22 13559 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
25 INDUMATHY 20 13599 1 3 3 3 3 3 3 3 3 3 3 3 3 3 
26 MYTHILI 24 13612 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
27 NANDHINI 20 13797 1 3 0 0 0 0 1 4 0 0 0 0 1 1 
28 KARPAGAM 25 13813 1 5 1 1 1 0 1 4 0 0 0 0 0 1 
29 ANJALACHI 20 13848 1 2 0 0 0 0 1 4 0 0 0 0 1 1 
30 BHARATHI 23 13885 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
 
 
31 SHARMILA 23 13909 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
32 NEELAVATHI 24 13827 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
33 ADHI 24 13927 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
34 SUSILA 25 13863 2 3 0 0 0 0 1 4 0 0 0 0 1 1 
35 INDHUMATHI 22 14133 1 4 0 0 0 0 1 4 3 3 3 3 3 3 
36 PACHAIYAMMA 24 14330 1 5 1 0 0 0 1 4 1 0 0 0 1 1 
37 LAKSHMI 23 14445 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
38 DEVI 26 14489 2 6 0 0 0 0 1 4 0 0 0 0 1 1 
39 RASATHI  22 14719 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
40 DEIVANAI 24 14784 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
41 SHOBANA 20 14924 1 3 0 0 0 0 1 4 0 0 0 0 1 1 
42 VALARMATHI 22 15108 1 4 0 0 1 0 1 4 0 0 0 0 1 1 
43 MALAR 23 15243 1 4 0 0 0 0 1 4 0 0 0 0 1 0 
44 KATTIYAMMA 24 15284 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
45 REVATHI 26 15456 2 4 3 3 3 3 3 3 3 3 3 3 3 3 
46 HEMALATHA 27 15649 2 6 0 0 0 0 1 4 0 0 0 0 1 1 
47 RANJITHA 21 15651 1 3 0 0 0 0 1 4 0 0 0 0 1 1 
48 AMUL 24 15977 1 4 0 0 1 0 1 4 0 0 0 0 1 1 
49 PRIYA 24 16184 1 4 0 0 0 1 0 0 3 3 3 3 3 3 
50 SHENBAGAVALLI 23 16201 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
51 SUDHA 24 16373 1 5 0 0 0 0 0 1 0 0 0 0 1 1 
52 NEELA 23 16519 1 4 0 0 1 0 1 4 0 0 0 0 1 1 
53 USHA 24 16594 1 4 0 0 0 0 1 4 0 0 1 0 1 1 
54 AMUTHA 25 17926 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
55 SUGASHREE 20 18757 1 3 3 3 3 3 3 3 3 3 3 3 3 3 
56 REVATHI 24 18999 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
57 NITHYA 25 19122 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
58 PUSHPARANI 24 19294 1 5 1 0 0 0 1 4 1 0 0 0 1 1 
59 SASIKALA 25 19447 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
60 DACHAYINI 23 19462 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
61 REVATHY 24 19432 1 5 0 0 0 0 1 4 0 0 0 0 0 1 
62 REKHA 24 19721 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
63 ANNAMMAL 25 19722 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
64 DEIVAANI 20 19955 1 3 3 3 3 3 3 3 3 3 3 3 3 3 
65 GOMATHI 24 19811 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
 
 
66 SONIA 25 20002 1 5 0 0 1 0 1 4 3 3 3 3 3 3 
67 ANJALAI 22 20079 1 2 0 0 0 0 1 4 0 0 0 0 1 1 
68 SANGEETHA 24 20162 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
69 GAYATHRI 21 20480 1 3 3 3 3 3 3 3 3 3 3 3 3 3 
70 RADHIKA 21 20551 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
71 BHARATHI 25 20246 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
72 RAMYA 23 20575 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
73 SASIREKA 23 20902 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
74 SARASWATHI 22 20937 1 4 0 0 0 0 0 0 3 3 3 3 3 3 
75 SHAMA 22 21205 1 2 0 1 0 0 1 4 0 0 0 0 1 1 
76 CHITHRA 23 21218 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
77 ADHILAKSHMI 24 21262 1 5 1 0 0 0 1 4 0 0 0 0 1 1 
78 AMBIKA 24 21404 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
79 SHOBANA 22 21458 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
80 SAVITHRI 22 21621 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
81 HEMAVATHI 27 21830 2 6 3 3 3 3 3 3 3 3 3 3 3 3 
82 SUMITHRA 22 21898 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
83 SELVI 20 21953 1 3 0 0 0 0 1 4 0 0 0 0 1 1 
84 SARASWATHI 24 21970 1 4 0 0 0 0 1 4 0 0 0 1 0 0 
85 LAITHA 25 22131 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
86 PADMAVATHY 23 22149 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
87 MANIMEGALAI 27 22197 2 6 0 0 0 0 1 4 0 0 0 0 1 1 
88 CHITHRA 21 22246 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
89 MALA 24 22284 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
90 SRIVIDHYA 25 22435 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
91 SARALA 25 22501 1 4 0 0 0 0 1 4 0 0 1 0 1 1 
92 SARITHA 25 22664 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
93 KUMARI 26 22828 2 4 0 0 0 0 1 4 0 0 0 0 1 1 
94 LAKSHMI 26 22845 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
95 SHENBAGAM 21 22920 1 3 0 0 1 0 1 4 0 0 0 0 0 1 
96 RIHANA 24 22969 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
 
 
97 VIJALAKSHMI 24 22986 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
98 KAVITH 20 23105 1 2 0 0 0 0 1 4 0 0 0 0 1 1 
99 ANJALAI 24 23289 1 4 0 0 0 0 1 4 0 0 0 1 0 0 
100 SHENBAGAVALLI 23 23837 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
101 RADHIKA 23 23312 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
102 KALPANA 25 23407 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
103 NAGAVALLI 25 23529 1 4 0 0 1 0 1 4 0 0 0 0 1 1 
104 KALAIVANI 21 23552 1 2 0 0 0 0 1 4 0 0 0 0 1 1 
105 AISHWARIYA 22 23151 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
106 JESSEY SANDHIYA 25 23964 1 5 1 1 1 0 1 4 0 0 0 0 1 1 
107 VASANTHA 21 24068 1 4 0 0 0 0 1 4 1 1 1 0 1 1 
108 KAMALA 25 23475 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
109 JANAKI 21 24040 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
110 SIVALAKSHMI 21 24105 1 3 0 0 0 0 1 4 0 0 0 0 1 1 
111 PADMAVATHY 25 23307 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
112 VIJAYALAKSHMI 21 24288 1 5 0 0 0 0 1 4 0 0 0 0 1 0 
113 RITA 25 24192 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
114 BHAVANI 24 24212 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
115 LATHA 21 24296 1 2 0 0 0 0 1 4 0 0 0 0 1 1 
116 KASTHURI 21 24320 1 5 0 0 1 0 1 4 0 0 0 0 0 1 
117 SUMATHI 26 24366 2 6 0 0 0 0 1 4 0 0 0 0 1 1 
118 VIJAYALAKSHMI 21 24533 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
119 JEYANTHI 24 24579 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
120 HEMAMALINI 22 24541 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
121 AMIRTHAM 20 24439 1 2 0 0 0 0 1 4 0 0 0 0 1 1 
122 BANUPRIYA 22 23850 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
123 SUDHA 24 24657 1 5 3 3 3 3 3 3 3 3 3 3 3 3 
124 SUGANTHI 23 24675 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
125 INDHIRA 22 24754 1 4 1 0 0 0 1 4 0 0 0 0 1 1 
126 NANDHINI 21 24744 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
127 RUBINI 20 24661 1 2 3 3 3 3 3 3 3 3 3 3 3 3 
 
 
128 VASANTHA 25 24703 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
129 MANJULA 22 24702 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
130 JESINTHA 28 24789 2 6 0 0 0 0 1 4 0 0 0 1 0 0 
131 PARAMESWARI 22 24914 1 4 0 0 1 0 1 4 0 0 0 0 1 1 
132 NADHIYA 23 24859 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
133 LAKSHMI 20 24852 1 2 0 0 0 0 1 4 0 0 0 0 1 1 
134 SANGEETHA 21 24984 1 3 3 3 3 3 3 3 3 3 3 3 3 3 
135 ALAMELU 23 24869 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
136 BANUPRIYA 22 23850 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
137 NEELA 22 25080 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
138 SHANTH 23 25011 1 4 0 0 0 0 1 4 0 0 0 0 1 1 
139 ANUSHYA 25 25112 1 5 0 0 0 0 1 4 0 0 0 0 1 1 
140 INDHUMATHI 25 25054 1 5 0 0 1 0 1 4 0 0 0 0 1 1 
141 POONGODI 24 25146 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
142 SANGEETHA 24 25220 1 4 0 0 0 1 0 0 3 3 1 3 3 3 
143 GOWRI 26 24962 2 4 0 0 0 0 1 4 0 0 0 0 1 1 
144 KAVITHA 26 24290 2 6 3 3 3 3 3 3 3 3 3 3 3 3 
145 ANITHA 21 25296 1 2 1 0 0 0 1 4 0 0 0 0 1 1 
146 REVATHI 25 25197 1 4 3 3 3 3 3 3 3 3 3 3 3 3 
147 SIVARANJANI 20 25372 1 4 0 0 0 0 0 0 3 3 3 3 3 3 
148 LALITHA 23 25400 1 4 0 0 0 0 1 4 3 3 3 3 3 3 
149 AMBIGA 24 25415 1 4 0 0 0 0 1 4 3 3 3 3 3 3 
150 SUDHA 24 25484 1 5 3 3 3 3 3 3 3 3 3 3 3 3 
 
 
 
 
 
 
 
 
 
KEYS FOR MASTER CHART 
AGE GROUP 
18-20 1 
21-25 2 
26-30 3 
>30 4 
 
EDUCATION STATUS GROUP 
ILLITRATE 1 
PRIMARY SCHOOL 2 
MID SCHOOL 3 
HIGHER SECONDARY 
SCHOOL 
4 
DIPLOMA 5 
DEGREE/ GRADUATE 6 
 
 
 
 
 
 
 
  
IUCD ON USG GROUP 
YES 1 
NO 0 
NOT DONE 4 
LOST FOLLOW UP 3 
PARITY GROUP 
PRIMI 1 
SECOND  2 
CRAMP GROUP 
YES 1 
NO 0 
LOST FOLLOW UP 3 
EXCESSIVE VAGINAL 
DISCHARGE 
GROUP 
YES 1 
NO 0 
LOST FOLLOW UP 3 
MENSTRUAL 
IRREGULARITIES 
GROUP 
YES 1 
NO 0 
LOST FOLLOW UP 3 
IUCD REMOVED GROUP 
YES 1 
NO 0 
LOST FOLLOW UP 3  
THREADS SEEN GROUP 
YES 1 
NO 0 
LOST FOLLOW UP 3 
 
 
ABBREVIATIONS 
CDC- Centre for Disease Control and prevention. 
CPR- Couple protection rate. 
CU T- Copper T. 
ESR-Erythrocyte sedimentation rate 
IUCD-Intra uterine contraceptive devices.  
LAM- Lactational Amenorrhea Method. 
MEC-Medical eligibility criteria. 
NSAIDS- Non steroidal anti-inflammatory drug. 
P/S- Per Speculum 
P/V- Per vaginum. 
PID- Pelvic inflammatory disease. 
PPIUCD- Postpartum intrauterine device. 
ROM- Rupture of membrane. 
USG- Ultrasonogram. 
WBC- White blood cells 
WHO- World health organisation. 
